CM
INBX icon

Caption Management’s Inhibrx INBX Stock Holding History

Caption Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-57,500
Closed -$1.94M – 1814
2025
Q3 		$1.94M Buy
+57,500
New +$1.42M 0.02% 857

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Caption Management's INBX Position: Q1 2026 in Review

Caption Management opened a new position in Inhibrx (INBX) in Q1 2026: 1,000 shares worth $67.2K. The stake represents ﹤0.01% of the portfolio and ranks #1417 among its holdings. This is a return to the name: Caption Management previously reported a position in INBX as recently as Q3 2025.

Caption Management first reported a position in INBX in Q2 2024 and has held it in 7 quarters since. The position peaked at $3.13M in Q3 2024. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Caption Management held 1,000 shares of Inhibrx worth $67.2K as of Q1 2026.
  • Inhibrx was a new Caption Management position in Q1 2026.
  • Inhibrx made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1417 holding.
  • Caption Management first reported a position in Inhibrx in Q2 2024 and has held it in 7 quarters since.
  • Caption Management's Inhibrx position peaked at $3.13M in Q3 2024.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.